Delivery Order SPE2DB20D3103-SPE2DB24FL7R0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,482.27 firm fixed-price delivery order is for the supply of Vigamox 0.5% eye drops (3 ml) to support military healthcare programs. The award has an ultimate completion date of April 11, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,745.56 firm-fixed-price delivery order contract is for the supply of Vigamox 0.5% eye drops, with a completion date of September 19, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award, valued at $2,552.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product used for medical treatment. This delivery order was issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as a...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of VIGAMOX 0.5% eye drops (3 ml) to support military healthcare programs. The contract, valued at $15,847.53, is a delivery order awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,922.30 Firm Fixed Price delivery order is for the drug Vigamox 0.5% eye drops in 3ml containers, with a completion date of May 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order valued at $5,016.28 for the procurement of Vigamox 0.5% eye drops. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which is valued at up to $999,999,999.00 and runs through November 2026. The contract is for the delivery of a wide...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,204.48 firm fixed-price delivery order is for the supply of Vigamox 0.5% eye drops, a specialty pharmaceutical product. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Vigamox 0.5% eye drops. The $5,468.64 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and...
- This federal contract award, valued at $1,074.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Vigamox 0.5% eye drops (3mL) and does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
- The U.S. government has awarded a Delivery Order contract worth $2,754.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Vigamox 0.5% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. This contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FL7R0Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $15,281.01 firm-fixed-price delivery order is for the supply of Vigamox 0.5% eye drops (3 mL) and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely one of many delivery orders placed against that IDC to fulfill the Department of Defense's (DoD) requirements for pharmaceutical products. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.3k | 12/4/23 |